Refine by
Mass Spectrometer Articles & Analysis: Older
96 news found
Profacgen, a leading provider of custom biotechnology services, is pleased to announce significant updates to its Antimicrobial Peptides (AMPs) Services, enhancing its capabilities to support the growing demand for alternative therapies in the fight against drug-resistant pathogens. As antibiotic resistance continues to pose a global health threat, Profacgen is expanding its services to assist ...
CD BioGlyco, a leading provider in the field of glycoproteomics, has recently updated its Glycoprotein Quantification Service. This enhancement aims to offer more precise and comprehensive glycoprotein analysis, catering to the growing demands in the fields of biomedical research, disease biomarker discovery, and therapeutic development. Protein glycosylation, a major post-translational ...
In a ground-breaking advancement for cardiovascular care, Hiden Analytical Ltd is proud to announce a surface measurement technique for devices critical in the treatment of heart disease. Utilizing the most sensitive surface analysis technology, Secondary Ion Mass Spectrometry (SIMS), Hiden Analytical is setting new standards in the safety, efficacy, and innovation of stent technology. Surgical ...
CD BioGlyco, a biotechnology company dedicated to developing a one-stop service in the field of glycomics, now provides professional and high-quality glycan derivatization services to give scientific assistance for researchers in need. Carbohydrates only absorb light at low wavelengths, which makes UV and fluorescence detection less sensitive. Additionally, low sensitivity in glycan analysis is ...
Stephen Haywood, Test and Installation Engineer at Hiden Analytical, recently installed an EQP Mass and Energy Analyser at the University of Strathclyde’s Biomedical Engineering Department. This revolutionary tool will accelerate their research on prosthetic ...
The 87th China International Medical Equipment Fair (CMEF) opened on 14 May at the National Convention and Exhibition Centre (Shanghai). The exhibition is a trendsetter in the global medical device industry and a "top tier" medical event, with brand representatives from more than 20 countries and regions from around the world showcasing sophisticated products spanning the entire industry chain ...
The need for high-quality pharmaceutical development services has never been more pressing. Therefore, in a swift response to such demand, CD Formulation has recently rolled out its new Pharmaceutical Formulation Characterization Testing (PFCT) services, a move aiming to help ensure that the newly developed pharmaceutical products are stable, effective, and in compliance with the regulatory ...
Bioinformatics-Analysis is a subdivision of CD Genomics, providing reliable next-generation and third-generation high-throughput sequencing data analysis, database construction, and other related data analysis services utilizing comprehensive technology. The Product Manager at CD Genomics is pleased to announce the launch of the LC-MS/MS Data Analysis service, enabling high-performance, regulated ...
As a leading provider of biopharmaceutical and proteomics analysis software, Protein Metrics will bring their deep expertise in mass spectrometry and computational challenges to the scheme. Working closely together with the Analytical Glycoimmunology Group, the US-based organisation will continue investing in research projects that look to investigate and resolve complex ...
Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform, and the Translational Genomics Research Institute (TGen), part of City of Hope, today announced a partnership to explore the utility of the Nautilus platform by studying specific protein targets in diffuse intrinsic pontine glioma (DIPG), a rare and often fatal ...
Pronalyse is a subdivision of Creative Proteomics, an integrated CRO company with rich experience in providing drug development services. Building on its years of experience, Creative Proteomics Pronalyse announces the launch of its fusion proteins characterization service to ensure the production of safe and effective therapeutic fusion proteins. Fusion protein refers to a new type of synthetic ...
NanoPin Technologies Inc, a biotechnology company focused on developing advanced diagnostics to improve the lives of millions of individuals affected by infectious diseases worldwide, announced the release of a scientific study conducted by founder Tony Hu, Ph.D. Dr. Hu is a professor and Weatherhead Presidential Chair in Biotechnology Innovation at the Tulane University School of Medicine. ...
xCures, Inc. is proud to announce their collaboration with mProbe Inc., a premier CLIA-certified targeted proteomics company. mProbe utilizes a proprietary technology platform integrating artificial intelligence and multi-omic diagnostics to transform the diagnosis, prevention, and treatment of complex diseases such as cancer. As the knowledge of cancer and its treatments advance, it is ever ...
ByxCures
The application of LC-MS/MS in biotechnological drug metabolite identification is a popular research topic. Meanwhile, high resolution mass spectrometry (HRMS) has gained increasing attention in recent years as a complete protein quantification strategy due to its ability to directly determine the content of protein drugs and metabolites. ...
BOC Sciences offers synthesis and conjugation of siRNA to the targeted peptide with high quality and yield, hoping to help researchers achieve substantial preclinical progress for RNAi therapeutics. The peptide-siRNA conjugation technology uses peptide as a carrier for nucleic acids to bring short siRNA into the body, thus exerting the gene silencing effect of siRNA specifically toward target ...
MOBILion System Inc. (Chadds Ford, PA), a life science tools and instrumentation company commercializing a best-in-class technology to separate, identify, and analyze the most challenging molecules other instruments fail to detect, announced that it has appointed Jenn Buechel to serve on its Board of Directors, effective immediately. Ms. Buechel, currently the Chief Operating Officer of Delfi ...
“We’re developing sensors that can rapidly and precisely measure the biomolecules that indicate quality, which is one of the key voids in modern biomanufacturing capabilities as there is a big question around what do we measure and how do we measure it when it matters.” Working with the Mass Spectrometer Andson’s innovations enable rapid ...
Profacgen, an experienced provider in biological research and drug discovery, provides various ubiquitin services to help customers accelerate research progress and obtain better results. Ubiquitination is one of the most prevalent post-translational modifications (PTMs) in cells. Ubiquitin modification induces protein degradation, which affects the function, localization, and activity of ...
STEMart, a provider of integrated medical device CRO services dedicated to medical device and diagnostic clinical development, expands its Biocompatibility Testing services and introduces biocompatibility evaluation of breathing gas pathways in medical devices. This new testing follows the biocompatibility guidelines modified for medical devices and uses a solid scientific rationale. ...
BySTEMart
Pronalyse, a division of Creative Proteomics, is an integrated CRO company with rich experience in providing drug development services. To ensure drug identity, strength, potency, purity, and safety, Creative Proteomics Pronalyse announced the launch of therapeutic enzyme characterization services. Enzymes play a major role in the pharmaceutical industry today due to their ability to ...